The development of iPSC haplobanks is revolutionizing regenerative medicine by enabling HLA-matched, off-the-shelf cell therapies. These banks make personalized treatment more efficient, reducing immune risk and manufacturing time for advanced therapies. https://xelleratherapeutics.bcz.com/2025/10/27/how-ipsc-haplobanks-are-revolutionizing-cell-therapy-and-personalized-medicine/